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O B J E C T I V E S We evaluated the association between pericardial fat and myocardial ischemia for
risk stratiﬁcation.
B A C KG ROUND Pericardial fat volume (PFV) and thoracic fat volume (TFV) measured from
noncontrast computed tomography (CT) performed for calculating coronary calcium score (CCS) are
associated with increased CCS and risk for major adverse cardiovascular events.
METHOD S From a cohort of 1,777 consecutive patients without previously known coronary artery
disease (CAD) with noncontrast CT performed within 6 months of single photon emission computed
tomography (SPECT), we compared 73 patients with ischemia by SPECT (cases) with 146 patients with normal
SPECT (controls) matched by age, gender, CCS category, and symptoms and risk factors for CAD. TFV was
automatically measured. Pericardial contours were manually deﬁned within which fat voxels were automat-
ically identiﬁed to compute PFV. Computer-assisted visual interpretation of SPECT was performed using
standard 17-segment and 5-point score model; perfusion defect was quantiﬁed as summed stress score (SSS)
and summed rest score (SRS). Ischemia was deﬁned by: SSS SRS4. Independent relationships of PFV and
TFV to ischemia were examined.
R E S U L T S Cases had higher mean PFV (99.1  42.9 cm3 vs. 80.1  31.8 cm3, p  0.0003) and TFV
(196.1  82.7 cm3 vs. 160.8  72.1 cm3, p  0.001) and higher frequencies of PFV 125 cm3 (22% vs.
8%, p 0.004) and TFV200 cm3 (40% vs. 19%, p 0.001) than controls. After adjustment for CCS, PFV
and TFV remained the strongest predictors of ischemia (odds ratio [OR]: 2.91, 95% conﬁdence interval
[CI]: 1.53 to 5.52, p  0.001 for each doubling of PFV; OR: 2.64, 95% CI: 1.48 to 4.72, p  0.001 for TFV).
Receiver operating characteristic analysis showed that prediction of ischemia, as indicated by receiver-
operator characteristic area under the curve, improved signiﬁcantly when PFV or TFV was added to CCS
(0.75 vs. 0.68, p  0.04 for both).
CONC L U S I O N S Pericardial fat was signiﬁcantly associated with myocardial ischemia in patients
without known CAD and may help improve risk assessment. (J Am Coll Cardiol Img 2010;3:1104–12)
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1105ericardial fat volume (PFV) and intrathoracic
fat volume (TFV) can be quantified from
noncontrast computed tomography (CT) scans
performed for coronary calcium scoring (CCS)
1,2). PFV measured on noncontrast CT is strongly
ssociated with coronary artery disease (CAD),
CS, severity of detected CAD, biochemical mark-
rs of systemic inflammation, and risk of future
dverse cardiovascular events (2–15). However,
hether any relationship exists between PFV and
yocardial ischemia has not been determined. Re-
ently, to overcome the excessive time and resources
eeded for quantifying PFV in a large cohort, we
sed a case-control study to demonstrate a signifi-
ant association between PFV and major adverse
ardiac event (MACE) risk (15). A case-control
tudy design is often used to initially assess the
pidemiologic importance of potentially novel dis-
ase markers, leading to subsequent prospective
esearch (16–18). We therefore conducted the fol-
owing case-control study to evaluate whether PFV
nd TFV obtained from noncontrast CT would
rovide additive value for identifying patients with
ncreased risk for ischemia in a group of patients
ith no previous history of CAD.
E T H O D S
atient population and CT imaging. Patients were
rawn from a cohort of 1,777 consecutive pa-
ients without known coronary artery disease
nrolled in the EISNER (Early Identification of
ubclinical Atherosclerosis Using Non-Invasive
maging Research) registry at Cedars-Sinai Medical
enter, who underwent noncontrast CT for CCS
nd myocardial perfusion single-photon emission
omputed tomography (SPECT) within 6 months
f each other (15.5  27.3 days between studies).
nclusion criteria for these patients were adults 45
o 80 years of age with intermediate pre-test prob-
bility for CAD defined by: 1) man 55 years of
ge or woman 65 years of age; or 2) man between
5 and 54 years of age or woman between 55 and 64
ears of age with at least 1 traditional CAD risk
actor. Patients with unstable angina, history of
yocardial infarction, coronary revascularization,
ardiomyopathy, peripheral artery disease, or stroke
ere excluded. In this cohort, there were 73 pa-
ients (population “cases”  73) with inducible
schemia (summed difference score 4). We
atched each patient with ischemia to 2 same-sex
ontrols using a propensity score. The technique of
ropensity score–based matching has been widely ased to simultaneously control many confounders
19,20). An overall score was first calculated for
ach patient using a probit model accounting for
ge, body mass index (BMI), Framingham risk
core (FRS), diabetes, clinical symptoms at the time
f SPECT, and CCS categories defined as CCS 
, CCS  1 to 99, CCS  100 to 399, and CCS
400) with a widely used STATA software module
StataCorp LP, College Station, Texas) (15,21).
ach case was then matched to 2 controls using
ingle nearest-neighbor matching, with no replace-
ent. A total of 219 patients (73 cases and 146
ontrols) thus comprised the study population. This
tudy was conducted according to guidelines of the
edars-Sinai Medical Center institutional review
oard. All patients provided written consent for use
f their data.
Noncontrast CT was acquired using an electron-
eam (e-Speed, GE Healthcare, Milwaukee, Wiscon-
in) or a 4-slice CT scanner (Somatom Volumezoom,
iemens Medical Solutions, Forchheim,
ermany). Both scanners were calibrated
aily using air and water phantoms. Each
can extended from the aortic arch to the
iaphragm and was obtained during a single
reath-hold. The following scan parameters
ere used: heart rate dependent, prospective,
lectrocardiography (ECG) triggering (typ-
cally 45% to 60% of the R-R interval),
5-cm field of view, and 512 512 matrix
ize. Tube voltage was 120 kVp with
ultislice scanning. Slice thickness was 3
m for electron-beam CT and 2.5 mm
or multislice CT.
All CT images were reviewed by an expert
eader, using semiautomatic commercially available
oftware (ScImage, Los Altos, California) to quan-
ify coronary calcium. Total Agatston CCS was
alculated as the sum of calcified plaque scores of all
oronary arteries (22). The CT images were trans-
erred to a research workstation for pericardial and
horacic fat quantification.
ericardial and thoracic fat quantiﬁcation. Pericardial
nd thoracic fat quantification was performed by
oftware (QFAT) developed at Cedars-Sinai Med-
cal Center (Los Angeles, California), as previously
escribed (1,15). Pericardial fat was defined as
dipose tissue enclosed by the visceral pericardium,
ncluding fat directly surrounding the coronary
rteries. Thoracic fat was defined as all adipose
issue within the chest at the level of the heart,
nclosed by the posterior limit of the heart and
A B B
A N D
CAD
CCS
CT
MACE
event
PFV
SPECT
comp
TFVbove the diaphragm, with the same craniaR E V I A T I O N S
A C R O N YM S
coronary artery disease
coronary calcium score
computed tomography
major adverse cardiac
(s)
pericardial fat volume
 single-photon emission
uted tomographyl and
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1106audal boundaries defined for pericardial fat. Tho-
acic fat comprised both pericardial and extraperi-
ardial fat.
For defining pericardial contours, the upper slice
imit, marked by bifurcation of the pulmonary
runk, and lower slice limit, identified as the slice
ust below the posterior descending artery, were
hosen. This lower limit was chosen to better
istinguish pericardial fat from fat around the
iaphragm. As in our previous work (1,15), 5 to 7
ontrol points on the pericardium in each transverse
iew were assigned by an expert reader blinded to
atient status and clinical noncontrast CT interpre-
ation. From these control points, piecewise cubic
atmull-Rom spline functions were automatically
enerated to create a smooth closed pericardial
ontour (23) for quantification of PFV and TFV (in
m3). Contiguous 3-dimensional voxels between
190 HU to30 HU were defined as fat voxels by
efault (4,24–26); these limits could be modified by
he user if deemed appropriate. Figure 1 shows a
ase example of PFV and TFV measurement.
xercise and adenosine stress SPECT protocols. Pa-
ients were instructed to discontinue beta-blockers
nd calcium antagonists 48 h and nitrates 24 h
efore testing. Rest perfusion images were acquired
0 min after infusion of 3 to 4.5 mCi of 201Tl
based on body weight). Stress testing was per-
ormed with a symptom-limited Bruce treadmill
xercise protocol or vasodilator challenge, as de-
cribed previously (27). At near-maximal exercise,
9mTc-sestamibi (32 to 40 mCi) was injected intra-
enously, after which treadmill exercise was contin-
ed at maximal workload for 1 min and at 1 stage
ower for 2 additional min whenever possible.
9mTc-sestamibi myocardial perfusion imaging
MPI) acquisition was started 15 to 30 min after
adiopharmaceutical injection. For vasodilator
Figure 1. Measurement of PFV and TFV From Noncontrast CT
Pericardial and thoracic fat quantiﬁcation from a noncontrast comp
axial slice with a clearly visible pericardium. This is manually delinea
quantiﬁcation of pericardial and extrapericardial thoracic fat represe
pericardial fat volume; TFV  thoracic fat volume.tress, adenosine was infused at 140 g/kg/min for
min; in ambulatory patients, a low-level treadmill
xercise was performed during adenosine infusion
28). At the end of the second minute, 99mTc-
estamibi (32 to 40 mCi) was injected, and myocardial
maging was started approximately 60 min later (29).
12-lead ECG was monitored continuously during
tress testing. Horizontal or downsloping ST-segment
epression 1 mm or upsloping 1.5 mm was
onsidered positive for ischemia.
PECT acquisition and reconstruction protocols. The
PECT images were acquired with a 2-detector
amma camera (Philips Adac Forte or Vertex, Philips
edical Systems, Cleveland, Ohio, or E-Cam, Sie-
ens Medical Solutions). High-resolution collimators
ere used, and acquisition consisted of 64 projections
ver a 180° orbit, with 64 projections at 25 s/projec-
ion for supine 99mTc acquisition followed immedi-
tely by 15 s/projection for prone 99mTc acquisition
30). Rest 201Tl acquisition was performed at 35
/projection in supine position only. At each of the 64
rojection angles, the image data were recorded into
6 equal ECG-gated time bins. No attenuation or
catter correction was applied. After iterative recon-
truction (12 iterations) with Butterworth pre-filtering
cutoff 0.66 cycle/pixel for supine 99mTc, 0.55 cycle/
ixel for prone 99mTc; order 5), short-axis images were
utomatically generated (31).
omputer-assisted visual quantiﬁcation of SPECT.
erfusion defect assessment on SPECT-MPI was
erformed using computer-assisted visual interpre-
ation by an expert reader with the standard 17-
egment, 5-point scoring model. The extent and
everity of perfusion defect was quantified as
ummed stress score (SSS) and summed rest score
SRS). The extent and severity of ischemia was
iven by summed difference score (SDS  SSS 
RS; SDS 4  abnormal) (32,33).
tomography (CT) for a 65-year-old male patient. (A) Shows an
by the reader (blue outline) as shown in (B), and software-based
d by red and yellow regions, respectively, is shown in (C). PFV uted
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1107tatistical analysis. Distributions of CCS, PFV, and
FV as continuous variables were non-normal and
ere thus described as mean  SD after normal-
zation with logarithmic adjustment. Base-2 loga-
ithmic transformation was chosen because each
nit increase represented a doubling of the variable
n question (15,34). Other continuous variables
ere described as mean  SD. Univariate compar-
sons between cases and controls were made using
he Student t test or the chi-square test, as appro-
riate. Conditional multivariable regression models
ere generated to evaluate the relationship between
FV, TFV, and CCS with ischemia. Model fit of
he conditional logistic regression analyses were
hecked using the likelihood ratio test to evaluate
hether addition of PFV and TFV improved pre-
iction of ischemia. To further examine potential
ncremental value of PFV and TFV over established
isk prediction strategies, receiver-operator charac-
eristic (ROC) curves were constructed and areas
nder the curve (AUCs) were compared (35). Dif-
erences in estimated sensitivity, specificity, and
ccuracy were compared using the McNemar test.
ssociations and differences with p values 0.05
ere considered significant. All statistical analyses
ere performed using STATA software (version
0, StataCorp LP).
E S U L T S
ur matching technique resulted in no significant
ifferences in age, gender, FRS, and BMI between
ases with ischemia and controls without ischemia
Table 1). The distribution of patients among the 4
CS categories was similar in cases and controls,
chi-square value  0.76, p  0.859). Mean log-
ransformed CCS was slightly increased in cases
ompared with controls (8.49  3.3 vs. 7.64  3.1,
 0.06); however, this was not statistically sig-
ificant. In the overall population, 40% of patients
ere symptomatic and 60% of patients were asymp-
omatic. Cases and controls were similar with re-
pect to the proportion of individuals who were
ymptomatic (angina, dyspnea, atypical chest pain,
nd dyspnea with angina or atypical chest pain, p 
.17). By definition, all cases included in our
nalysis had inducible ischemia, with mean SSS
alues of 10.5  7.3 and mean SDS values of 9.9 
.8, and none of the controls had inducible isch-
mia, with mean SSS values of 0.1  0.4 and SDS
alues of 0.1  0.3.
In 20 patients in this cohort, PFV and TFV were
nalyzed by 2 independent observers. There wasxcellent correlation between the 2 observers for
FV and TFV (R  0.98, p  0.0001 and R 
.99, p  0.0001, respectively). The intraobserver
ariability was 8.4  5.8% for PFV and 2.4  4.1%
or TFV, similar to our previous study with the
ame software (1,15). Overall, mean PFV was
6.5  36.9 cm3 and mean TFV was 172.5  77.4
m3. The PFV and TFV were highly correlated to
ach other (r  0.86, p  0.0001). Cases had
ignificantly greater mean PFV (99.1  43 cm3 vs.
0  32 cm3, p  0.0003) and TFV (196 83 cm3
s. 161 72 cm3, p 0.001) than controls. Figure 2
hows an example of a case-control pair. In a
nivariate analysis, PFV 125 cm3 and TFV 200
m3 were associated with ischemia, and a greater
roportion of cases compared with controls had
FV 125 cm3 (22% vs. 8%, p  0.004) and TFV
200 cm3 (40% vs. 19%, p 0.001). Therefore, we
onsidered 3 equally spaced thresholds about these
alues (for PFV: 100 cm3, 125 cm3, and 150 cm3;
or TFV: 175 cm3, 200 cm3, and 225 cm3). In Table 2,
he sensitivity and positive predictive value (PPV)
or both PFV and TFV for detection of myocardial
schemia are low, but the specificity and negative
redictive value are higher.
ultivariable and ROC analysis. In multivariable
nalysis that adjusted for age, BMI, presence of
ymptoms, and traditional risk factors, the only
ariables that showed a significant association with
schemia were log-transformed CCS, PFV, and
FV (Table 3). The odds ratio (OR) of ischemia
or each doubling of PFV was 2.68 (95% confidence
Table 1. Characteristics of Patients Included in Analysis
Cases (n  73) Controls (n 
Age (yrs) 60.3 10.4 58.9 9.
Male 90.4 90.4
BMI (kg/m2) 28.1 4.6 27.1 3.
Log2 (CCS)* 8.49 3.3 7.64 3.
Framingham risk score 13.34 8.3 11.84 6.
Diabetes 10.9 12.3
Hypertension 70.6 82.2
Hyperlipidemia 74.7 76.7
Family history of CAD 28.8 31.5
Active smoking 14.4 13.7
Symptomatic 37 46
CCS categories†
0–99 8 10
100–399 11 13
400–999 19 21
1,000 62 56
Values are mean  SD or %. *Logarithmic transform of CCS was performed to
distribution. †Comparison across all CCS categories.146) p Value
4 0.35
1.00
8 0.12
1 0.06
9 0.16
0.76
0.06
0.74
0.68
0.89
0.17
0.86
—
—
—
—
adjust for its non-normalBMI  body mass index; CAD  coronary artery disease, CCS  coronary calcium score.
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1108nterval [CI]: 1.33 to 5.41, p  0.006) and for each
oubling of CCS was 1.29 (95% CI: 1.08 to 1.57,
 0.006). In the model with TFV, the OR for
schemia for each doubling of TFV was 2.59 (95%
I: 1.33 to 5.41, p  0.005) and for each doubling
f CCS was 1.33 (95% CI: 1.1 to 1.59, p  0.003).
hen adjusting only for CCS, PFV, or TFV, PFV
nd TFV remained strongly associated with isch-
mia (OR: 2.91, 95% CI: 1.53 to 5.52, p  0.001
er doubling of PFV vs. OR: 1.26, 95% CI: 1.05 to
.51, p  0.01 per doubling of CCS; OR: 2.64,
5% CI: 1.48 to 4.72, p  0.005 per doubling of
FV vs. OR: 1.28, 95% CI: 1.08 to 1.53, p 0.001
er doubling of CCS) (Table 4). The PFV was
eakly correlated with CCS (Spearman rho coeffi-
ient 0.15, p  0.02), but TFV was not correlated
Spearman rho 0.12, p  0.07).
In ROC analysis, when PFV or TFV was incre-
entally added to CCS, prediction of ischemia by
Figure 2. Representative Example of PFV, TFV, and Myocardial
Association of increased pericardial fat and thoracic fat with ischem
nal, and sagittal sections of a noncontrast CT with pericardial fat in
the right show a polar map of rest and stress myocardial perfusion
sion deﬁcit. The top panel represents a patient with ischemia (case
the bottom panel represents a control patient with PFV, TFV, and C
cium score; other abbreviations as in Figure 1.
Table 2. Sensitivity, Speciﬁcity, and PPV and NPV for PFV and T
Threshold Sensitivity Speciﬁcity
PFV 100 cm3 37.0* 78.8*
PFV 125 cm3 21.9* 91.8*
PFV 150 cm3 12.3* 97.3*
TFV 175 cm3 47.9 68.5*
TFV 200 cm3 41.1 80.8*
TFV 225 cm3 30.1 87.0*
*Signiﬁcantly different (p  0.05) across 3 cut points.
NPV  negative predictive value; PFV  pericardial fat volume; PPV  positive prPECT, as indicated by the ROC AUC, increased
ignificantly from 0.68 to 0.75 (p  0.04) for PFV and
rom 0.68 to 0.75 (p 0.04) for TFV (Figs. 3 and 4). In
ontrast, association of extrapericardial thoracic fat
defined as: TFV  PFV) with ischemia was much
ower (OR: 1.83, 95% CI: 1.18 to 2.84, p  0.007),
ith smaller, nonsignificant increases in the ROC
UC (0.68 to 0.72, p  0.12) when incrementally
dded to CCS.
I S C U S S I O N
ur results showed that PFV and TFV measured
y noncontrast CT are strongly associated with
schemia by SPECT; to our knowledge, this is the
rst demonstration of the additive value of PFV and
FV for prediction of ischemia.
It has been suggested that pericardial fat may
imply be a marker of overall metabolic risk rather
emia in a Matched Case-Control Pair
he top and bottom panels show (from left to right) axial, coro-
and thoracic extrapericardial fat in yellow. The last 2 panels on
h the darkest region representing the region of greatest perfu-
th PFV, TFV, and CCS of 136 cm3, 227 cm3, and 150, respectively;
of 90 cm3, 198 cm3, and 177, respectively. CCS  coronary cal-
Thresholds for Detection of Ischemia
PV NPV # of Controls # of Cases
6.6 71.4 31 27
7.1 70.2 12 16
9.2 68.9 4 9
3.2 72.5 46 35
1.7 73.3 28 30
3.7 71.3 19 22Isch
ia. T
red
, wit
) wi
CSFV
P
4
5
6
4
5
5edictive value; TFV  thoracic fat volume.
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1109han serving as an active mediator of CAD (4–
,9,10); however, recent studies have shown that
ncreased pericardial fat is strongly associated with
ncreased coronary artery calcium, coronary plaque
urden, and MACE. These findings and our ob-
ervations of the strong association between peri-
ardial fat and ischemia suggest that pericardial fat
ay play a more direct role in causing coronary
therosclerosis (1,7,8,12–15,38).
Although the exact pathophysiologic mechanism
as not been characterized, it has been hypothe-
ized that pericardial fat releases inflammatory sig-
als that promote atherogenesis in coronary arteries
6,12). It is thought that close proximity of pericar-
ial fat to the coronary arteries may play a role in
romoting atherogenesis (9,10). In a recent study,
ahabadi et al. (38) showed that there is a strong
ndependent association between the local pericar-
ial (pericoronary) fat that immediately surrounds
he coronary arteries and the presence of both
oncalcified and calcified coronary artery plaques.
ore recently Janik et al. (39) showed—in a small
ohort of 45 patients—that epicardial fat is associ-
ted with ischemia by positron emission tomogra-
hy and may be a better predictor of ischemia than
CS. The association between increased pericardial
at and ischemia seen in our study may be related to
he paracrine effect exerted by pericardial and peri-
oronary artery fat on coronary atherosclerosis as
ostulated by Mahabadi et al. (38).
We recently showed that PFV exhibits a signif-
cant association with MACE after adjustments for
raditional risk factors for CAD and the FRS in a
ase-control study (15). In a large population-based
tudy, pericardial fat was also found to be strongly
ssociated with a history of adverse cardiovascular
vents (8). Our observations further highlight the
elationship between pericardial fat and CAD by
emonstrating that there is a strong association
etween PFV and myocardial ischemia.
The relative importance of PFV and TFV in
ediating coronary atherosclerosis has been a sub-
ect of investigation. Rosito et al. (9) showed that
FV but not TFV was associated with coronary
alcification. Mahabadi et al. (10) showed that
FV, but not intrathoracic fat (equivalent to the
xtrapericardial TFV in our study) measured using
oncontrast CT, was related to burden of prior
ardiovascular disease after adjustment for age, sex,
MI, and waist circumference, suggesting that
FV may be a more specific disease marker. In our
nalysis, PFV and TFV were dependent variables
nd increased linearly. Increases in PFV and TFVere both associated with myocardial ischemia. In
econdary analysis, the relationship between extra-
ericardial fat (TFV  PFV) and ischemia was less
ignificant than the association between PFV and
schemia, indicating that the association of TFV is
ainly driven by PFV. Our findings suggest that fat
tores that immediately surround the coronary ar-
ery may have an impact on myocardial ischemia.
hese findings are consistent with our previous
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1110tudy demonstrating the preferential association
etween PFV over TFV and risk of MACE (15).
The sensitivity and PPV for both PFV and TFV
or detection of myocardial ischemia are low, but
he specificity and negative predictive value are
igher. The low sensitivity and PPV are expected
ecause this measurement of fat around the coro-
ary arteries is not a direct assessment of the
resence of abnormality within the coronary arter-
es. However, the higher specificity suggests that
ericardial fat measurement may potentially help
efine population subgroups in which further eval-
ation of myocardial ischemia may be warranted. A
CS 400 is traditionally considered to define
atients who need further evaluation for ischemia
34,36,37). In patients with metabolic syndrome or
iabetes the observed frequency of myocardial isch-
mia has led to a suggestion that a CCS 100 may
e a more appropriate threshold (36,40). Our find-
ngs suggest that increased PFV may also define a
atient group in which a lower threshold for isch-
mia testing may be appropriate. The significant
elationship between pericardial fat and myocardial
schemia in our study needs to be further investi-
Table 3. Conditional Multivariable Regression Analysis
Adjusting for BMI, Traditional Risk Factors, Symptoms, CCS,
and PFV or TFV
OR (95% CI)* p Value
Analysis with PFV
BMI (kg/m2) 1.00 (0.93–1.09) 0.86
Log2 (CCS)† 1.29 (1.08–1.57) 0.006
Diabetes 1.24 (0.44–3.45) 0.68
Hypertension 1.58 (0.71–3.49) 0.26
Hyperlipidemia 1.03 (0.49–2.12) 0.07
Family history of CAD‡ 1.36 (0.68–2.68) 0.38
Active smoking 1.19 (0.46–3.08) 0.71
Symptomatic 1.95 (0.96–3.97) 0.06
Log2 (PFV)† 2.68 (1.33–5.41) 0.006
Analysis with TFV
BMI (kg/m2) 1.00 (0.92–1.09) 0.98
Log2 (CCS)* 1.33 (1.10–1.59) 0.003
Diabetes 1.14 (0.42–3.07) 0.79
Hypertension 1.55 (0.70–3.43) 0.28
Hyperlipidemia 0.96 (0.46–1.98) 0.90
Family history of CAD‡ 1.40 (0.71–2.77) 0.33
Active smoking 1.24 (0.49–3.11) 0.65
Symptomatic 1.97 (0.96–3.99) 0.06
Log2 (TFV)* 2.59 (1.33–5.41) 0.005
*The odds ratio (OR) for ischemia associated with each variable included in
the multivariable analysis is given with 95% conﬁdence interval (CI) in
parentheses. †Logarithmic transform of CCS, PFV, and TFV was performed to
adjust for their non-normal distributions. ‡Family history of premature CAD.
Abbreviations as in Tables 1 and 2.ated with additional whole cohort studies.We have previously shown that a greater number
f patients who experienced MACE had a PFV
125 cm3 compared with event-free controls (15).
n this study, we report that a similar threshold of
FV may confer increased risk of myocardial isch-
mia; an increased proportion of patients with
schemia exhibit PFV 125 cm3 compared with
onischemic controls.
In our study, patients (cases and controls) were
atched based on standard CCS categories (CCS 0
o 99, CCS 100 to 399, CCS 400 to 999, and CCS
1,000). Therefore, after matching, the categories
ere not significantly different (p 0.86); however,
og-transformed CCS was not matched, and there
s a trend toward significant difference (p  0.06)
or log-transformed CCS between cases and con-
rols in univariate analysis. In multivariable analysis,
og-transformed CCS was significantly associated
ith myocardial ischemia. However, because we
atched cases and controls based on CCS catego-
ies to minimize the confounding effects of CCS,
urther examination of the relative strengths of
CS and PFV through a whole-cohort study is
eeded. Our current results lead us to hypothesize
hat increases in the number of future cardiac events
n patients with high PFV and TFV may be related
o an increased risk of myocardial ischemia.
hether the risk of ischemia in this patient cohort
s related to an increase in coronary plaque burden,
tenosis severity, or abnormal endothelial reactivity
till remains to be characterized.
tudy limitations. A case-control study design, al-
hough commonly used to assess the epidemiologic
mportance of potentially novel disease markers
16,17), is more sensitive to the effects of confound-
ng factors than a cohort study design. We chose a
ase-control design with rigorous matching of po-
ential confounding variables because complete
uantification of both PFV and TFV in a large
opulation using currently available techniques
Table 4. Conditional Multivariable Regression Analysis
Adjusting for CCS and PFV or TFV
OR (95% CI)* p Value
Analysis with PFV
Log2 (CCS)† 1.26 (1.05–1.50) 0.01
Log2 (PFV)† 2.91 (1.53–5.52) 0.001
Analysis with TFV
Log2 (CCS)† 1.28 (1.08–1.53) 0.005
Log2 (TFV)† 2.64 (1.48–4.72) 0.001
*The OR for ischemia associated with each variable included in the multiva-
riable analysis is given with 95% CI in parentheses. †Logarithmic transform of
CCS, PFV, and TFV was performed to adjust for their non-normal distributions.Abbreviations as in Tables 1, 2, and 3.
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1111ould be prohibitively time and labor intensive.
ur study population consisted of patients without
reviously known CAD who underwent CCS and
PI by SPECT whether symptomatic or asymp-
omatic; however, symptoms were matched be-
ween cases and controls and were therefore not
ignificantly different (Table 1). Furthermore, PFV
nd TFV emerged as predictors of ischemia in a
ultivariable analysis. C-reactive protein was not
vailable for most of our patients, and correlation of
-reactive protein with PFV or ischemia could not
e assessed. Our matching for CCS categories
inimized the importance of CCS in multivariable
nalysis. Although our results suggest additive util-
ty of pericardial fat to traditional risk-stratifyinga substudy of the Multi-Ethnic Study of
16. Birjmohun RS, D
Kuivenhoven JA, eonfirmation through longitudinal whole-cohort
valuation is needed.
O N C L U S I O N S
ericardial fat was associated with myocardial isch-
mia in patients without known CAD and may be
mportant for risk stratification.
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